SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

24 Jan 2024 Evaluate
The sales declined to Rs. 4715.20 millions for the December 2023 quarter as compared to Rs. 5378.42 millions during the corresponding quarter last year.Net Profit of the company move down -36.12% to Rs. 493.10  millions from Rs. 771.97 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 1252.34 millions from 1662.67 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4715.20 5378.42 -12.33 14045.58 16262.22 -13.63 21884.00 15509.41 41.10
Other Income 24.64 -2.61 -1044.06 49.92 34.45 44.91 79.84 41.11 94.21
PBIDT 1252.34 1662.67 -24.68 3308.11 5377.30 -38.48 6969.81 5135.97 35.71
Interest 201.93 210.31 -3.98 598.01 465.14 28.57 655.02 442.70 47.96
PBDT 1050.41 1452.36 -27.68 2710.10 4912.16 -44.83 6314.79 4693.27 34.55
Depreciation 308.78 308.39 0.13 931.88 788.24 18.22 1089.53 859.06 26.83
PBT 741.63 1143.97 -35.17 1778.22 4123.92 -56.88 5225.26 3834.21 36.28
TAX 248.53 372.00 -33.19 587.02 1358.34 -56.78 1691.68 1306.36 29.50
Deferred Tax 112.71 165.14 -31.75 259.30 616.09 -57.91 748.61 609.63 22.80
PAT 493.10 771.97 -36.12 1191.20 2765.58 -56.93 3533.58 2527.85 39.79
Equity 415.50 415.50 0.00 415.50 415.50 0.00 415.50 415.50 0.00
PBIDTM(%) 26.56 30.91 -14.08 23.55 33.07 -28.77 31.85 33.12 -3.82

Epigral Share Price

1130.00 29.35 (2.67%)
13-Apr-2026 13:53 View Price Chart
Peers
Company Name CMP
BASF India 3599.00
Tata Chemicals 725.00
SRF 2458.30
Pidilite Inds. 1331.45
Deepak Nitrite 1458.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×